Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists.

Details

Serval ID
serval:BIB_D19511222818
Type
Article: article from journal or magazin.
Publication sub-type
Case report (case report): feedback on an observation with a short commentary.
Collection
Publications
Title
Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists.
Journal
Journal of Maternal-fetal and Neonatal Medicine
Author(s)
Vendemmia M., Garcia-Méric P., Rizzotti A., Boubred F., Lacroze V., Liprandi A., Simeoni U.
ISSN
1476-7058 (Print)
ISSN-L
1476-4954
Publication state
Published
Issued date
2005
Peer-reviewed
Oui
Volume
18
Number
2
Pages
137-140
Language
english
Notes
Publication types: Case Reports ; Journal Article, pdf : Case Report
Abstract
Sartans are selective type 1 angiotensin II receptor-antagonists that are used in the treatment of arterial hypertension. Few reports are available concerning the use of sartans during pregnancy. We report two cases of adverse fetal outcome in hypertensive pregnancies exposed to sartans. In the first case, anamnios and fetal renal failure due to severe tubular dysgenesia led to termination of pregnancy in the 27th week. The second patient presented with hypocalvaria and developed fetal renal failure. The use of sartans during the two last trimesters of pregnancy should be strictly avoided.
Keywords
Abnormalities, Multiple/chemically induced, Abnormalities, Multiple/diagnosis, Adult, Angiotensin II/antagonists & inhibitors, Angiotensin-Converting Enzyme Inhibitors/adverse effects, Diagnosis, Differential, Female, Humans, Hypertension/drug therapy, Infant, Newborn, Male, Pregnancy, Pregnancy Complications, Cardiovascular/drug therapy
Pubmed
Web of science
Create date
22/02/2015 12:03
Last modification date
20/08/2019 15:51
Usage data